Status:
COMPLETED
Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 Mutations
Lead Sponsor:
Royal Devon and Exeter NHS Foundation Trust
Collaborating Sponsors:
Wellcome Trust
Hôpital Necker-Enfants Malades
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this study is to investigate whether patients with diabetes due to Kir6.2 mutations can be treated with sulfonylurea medication rather than insulin, and if this is the case to investiga...
Eligibility Criteria
Inclusion
- Diabetes due to KCNJ11 (Kir6.2) mutation
Exclusion
- None
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
End Date :
January 1 2006
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00334711
Start Date
January 1 2004
End Date
January 1 2006
Last Update
November 29 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.